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        Introduction 
  HECT (homologous to the E6AP C terminus) ubiquitin ligases 
share a common protein organization, encoding an N-terminal 
C2 domain involved in membrane binding, several centrally lo-
cated WW domains that bind to PPxY motifs, and a C-terminal 
HECT domain possessing the ubiquitin binding and ligase 
activities. HECT ubiquitin ligases have diverse functions in eu-
karyotic cells (  Ingham et al., 2004  ), largely through their ability 
to modify target proteins with mono- or polyubiquitin, thereby 
affecting protein localization, interactions, and stability. For ex-
ample, HECT ubiquitin ligases modulate the levels or localiza-
tion of proteins involved in the control of the actin cytoskeleton 
(RhoA;   Zhang et al., 2004  ), surface receptors such as CXCR4 
(  Marchese et al., 2003  ), transcription factors in TGF-     signal-
ing (  Zhang et al., 2001  ), and factors that modulate Notch signal-
ing (  Bray, 2006  ) as well as several tumor suppressors, including 
Smad4 (  Moren et al., 2005  ) and p53 (  Laine and Ronai, 2007  ). 
HECT ubiquitin ligases are also exploited by several enveloped 
viruses to initiate the recruitment of the ESCRT (endosomal 
sorting complex required for transport) machinery that mediates 
viral budding (  Martin-Serrano et al., 2005  ;   Chung et al., 2008  ; 
  Usami et al., 2008  ). 
 In two independent screens for proteins that bind to HECT 
ubiquitin ligases, we identifi  ed Spartin as a WWP1-binding pro-
tein. Spartin, also know as SPG20, is mutated in a rare neuronal 
disease, termed Troyer syndrome (  Patel et al., 2002  ). This syn-
drome is a complicated hereditary spastic paraparesis, which is 
characterized by distal muscle wasting, mental retardation, and 
dysarthria in addition to the lower extremity paraparesis and 
spasticity that characterize   “  pure  ”   hereditary spastic paraparesis. 
SPG20 is ubiquitously expressed and encodes a microtubule 
interaction and traffi  cking (MIT) domain at its N terminus, which 
is also found in the related protein SPG4 (Spastin;   Ciccarelli 
et al., 2003  ) as well as in the class E vacuolar protein sorting 
ATPase, VPS4 (  Scott et al., 2005  ;   Obita et al., 2007  ;   Stuchell-
Brereton et al., 2007  ), both of which bind to components of the 
ESCRT machinery (  Obita et al., 2007  ;   Stuchell-Brereton et al., 
2007  ;   Hurley and Yang, 2008  ). Additionally, SPG20 encodes a 
domain of unknown function toward its C terminus, which is de-
fi  ned by homology to proteins that are up-regulated during plant 
senescence (  Ciccarelli et al., 2003  ). There is some confusion as 
to the function of SPG20 in cells, as some investigators have 
reported that it binds to EPS15 and plays a role in endocytosis 
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dependent on the SPG20 PPxY motif, but deletion of either of 
the MIT domain or residues C terminal to position 1,110 
(mimicking the   SPG20   mutation in Troyer syndrome) had no 
effect on WWP1 binding (  Fig. 1 C  ). These results were con-
fi  rmed using yeast two-hybrid assays (  Fig. 1 F  ). Further yeast 
two-hybrid assays revealed that the central WW domains of 
WWP1 were necessary and suffi   cient for interaction with 
SPG20 (  Fig. 1 G  ). Thus, SPG20  –  WWP1 interaction appeared 
to be mediated exclusively by the PPxY motif in SPG20 and 
the WW domains in WWP1. Yeast two-hybrid analyses re-
vealed that SPG20 could bind to the WW domains from sev-
eral HECT ubiquitin ligases, specifi  cally WWP1, WWP2, 
Itch, Smurf1, and Smurf2, but did not bind to WW domains of 
other HECT ubiquitin ligases, namely Nedd4, Nedd4-L, and 
Bul-1 (  Fig. 1, D and E  ). 
  Colocalization of SPG20 and WWP1 
  Overexpression of CFP-SPG20 in 293T cells resulted in the for-
mation of large, apparently spherical, clustered vesicular struc-
tures within the cytoplasm (  Fig. 1 H  ). Upon coexpression of 
CFP-SPG20 with YFP-WWP1, the localization of both proteins 
changed, and extensive colocalization was observed (  Fig. 1 H  ). 
Ordinarily, YFP-WWP1 localizes primarily at the plasma 
  membrane (  Martin-Serrano et al., 2005  ). However, when co-
expressed with CFP-SPG20, a portion of WWP1 relocalized to 
the CFP-SPG20  –  labeled vesicular structures. Moreover, a por-
tion of CFP-SPG20 was relocalized to the plasma membrane 
when coexpressed with WWP1 (  Fig. 1 H  ). Colocalization ex-
periments using overexpressed WWP1 fragments (YFP  WW-HECT , 
YFP  C2-WW ,  YFP HECT ,  and  YFP WW  ) revealed that fragments that 
included the WW domain colocalized extensively with CFP-
SPG20, and YFP  C2-WW   overexpression caused CFP-SPG20 to 
relocalize to the plasma membrane (  Fig. S1  ). Conversely, upon 
coexpression of CFP-SPG20 with YFP  HECT  , there was no colo-
calization or any change in the distribution of either protein 
(Fig. S1, bottom). Thus, the WW domain of WWP1 meditates 
WWP1 recruitment to SPG20-containing structures, which is 
consistent with the fi  nding that the WW domains of WWP1 
bind to SPG20. 
  Use of virus release-based assays to 
demonstrate HECT ubiquitin ligase 
recruitment by Spartin/SPG20 
  Several enveloped viruses, including murine leukemia virus 
(MLV), engage cellular machinery required for virus particle 
release using PPxY-based   “  late-domain  ”   peptide motifs that re-
cruit ubiquitin ligases. If the SPG20 PPxY motif indeed bound 
to HECT ubiquitin ligases in a cellular environment, we rea-
soned that it should substitute for a motif within the MLV Gag 
protein that is known to recruit HECT ubiquitin ligases and 
thereby induce viral budding. Therefore, we substituted the 
MLV late domain with a motif corresponding to 14 aa residues 
centered around the PPxY motif in SPG20. Notably, this con-
struct, termed MLV-SPG20, effi   ciently generated infectious 
MLV virions, at least 200-fold more effi  ciently than the back-
ground level generated by an MLV lacking the PPPY motif 
(  Fig. 2, A and B  ). Moreover, MLV-SPG20 release was highly 
(  Bakowska et al., 2005  ,   2007  ), whereas others have suggested 
that it localizes to mitochondria (  Lu et al., 2006  ). Additional ex-
periments have suggested that SPG20 has a complex pattern of 
subcellular distribution, including transient localization with 
the TGN, as well as synaptic vesicles and discrete undefi  ned 
puncta within terminally differentiated neuroblastoma cells 
(  Robay et al., 2006  ). 
  In this study, we show that rather than associating with 
endosomal compartments and ESCRT proteins, SPG20 associ-
ates with the surface of lipid droplets (LDs). LDs are dynamic 
organelles that are the primary site for the storage of neutral 
lipids (  Welte, 2007  ). They are believed to form within mem-
branes of the ER, are transported along microtubules, and can 
be mobilized for lipolysis by adipose triglyceride lipase in re-
sponse to changes in metabolic conditions (  Brasaemle, 2007  ). 
LD surfaces display several specifi  c proteins, including pro-
teins of the perilipin (PAT) family such as adipophilin/adipocyte 
differentiation-related protein (ADRP) as well as TIP47 (tail-
interacting protein of 47 kD), OXPAT/myocardial LD protein, 
and S3-12. These proteins may dynamically exchange between 
cytoplasmic- and LD-associated fractions (  Londos et al., 2005  ; 
  Listenberger et al., 2007  ). 
  We also fi  nd that SPG20 binds to the LD-localized protein 
TIP47. Interestingly, a mutant SPG20 present in Troyer syn-
drome fails to localize to LDs and does not bind TIP47. More-
over, ADRP and SPG20 appear to compete for LD surfaces and 
mutually exclude each other from LDs. Importantly, depletion 
of SPG20 from cells using RNA interference causes increases 
in both the number and size of LD when cells are fed with oleic 
acid (OA). Finally, SPG20 is ubiquitinated, does not accumu-
late on the surfaces of LDs, and is degraded under conditions 
of HECT ubiquitin ligase (WWP1) overexpression, suggesting 
that the protein composition of LDs, and by inference lipid stor-
age, may be regulated by HECT ubiquitin ligases. Overall, these 
experiments suggest potential molecular mechanisms for the 
pathology of Troyer syndrome and a role for ubiquitin ligases 
and SPG20 in the regulation of LD turnover. 
  Results 
  Identiﬁ  cation of Spartin/SPG20 as a HECT 
ubiquitin ligase  –  binding protein 
  In screens to identify proteins that interact with HECT ubiquitin 
ligases, we used yeast two-hybrid and tandem affi  nity purifi  cation 
(TAP) approaches using full-length WWP1 as bait. Both screens 
identifi  ed several cellular proteins (unpublished data), but only 
one, namely SPG20, was identifi  ed by both approaches. SPG20 
consists of an N-terminal MIT domain linked to a poorly charac-
terized domain, which also contains a PPxY motif (  Fig. 1 A  ). In 
the case of the yeast two-hybrid screen, an N-terminally trun-
cated SPG20 (a deletion of residues 1  –  129, i.e., lacking the 
MIT domain;   Fig. 1 A  ) was identifi  ed. 
  Coprecipitation experiments using full-length SPG20 
fused to GST expressed in 293T cells showed that GST-
SPG20 could coprecipitate YFP-WWP1 (  Fig. 1 B  ). In recip-
rocal experiments, GST-WWP1 coprecipitated YFP-SPG20 
(  Fig. 1 C  ). The coprecipitation of SPG20 and WWP1 was 883 SPG20 AND LIPID DROPLETS   • Eastman et al. 
and YFP-WWP1 extensively colocalized in puncta at the plasma 
membrane (  Fig. S2 A  ). Notably, simultaneous overexpression 
of SPG20, but not SPG20 possessing a mutated PPPY domain 
(SPG20dPY), blocked YFP-WWP1 recruitment to MLV Gag-CFP 
puncta (Fig. S2, B and C). Additionally, overexpression of either 
full-length SPG20 or the MIT domain  –  deleted variant substan-
tially reduced the release of MLV virions (  Fig. 2, C and D  ) 
but had no effect on MLV-p6 (  Fig. 2 D  ). This inhibition of MLV 
release was largely dependent on the SPG20 PPxY motif, as ex-
pression of SPG20dPY had only marginal effects (  Fig. 2 C  ). 
  Intact SPG20 but not the Troyer syndrome 
variant is an LD-associated protein 
  We generated cell lines constitutively expressing SPG20 with 
both N- and C-terminal fusions of YFP, Cherry fl  uorescent 
sensitive to the inhibition by a C-terminally truncated version of 
WWP1 lacking the HECT domain (  Fig. 2, A and B  ), which is a 
potent inhibitor of wild-type MLV budding (  Martin-Serrano et al., 
2005  ). Importantly, an isogenic control virus, MLV-p6, that con-
tains a PTAP late domain and does not require HECT ubiquitin li-
gases for budding (  Fig. 2 B  ) was not inhibited by the truncated 
WWP1 protein. Thus, transplantation of the SPG20 PPxY motif 
into a heterologous context conferred the ability to recruit HECT 
ubiquitin ligases. 
  The MLV Gag protein can effi  ciently recruit WWP1 to na-
scent viruslike particles at the plasma membrane in a PPxY-
dependent manner. We reasoned that if the interaction of SPG20 
and WWP1 was authentic, SPG20 might compete with MLV Gag 
that normally binds to WWP1, block WWP1 recruitment, and in-
hibit virus particle release. Coexpressed CFP-tagged MLV Gag 
  Figure 1.       SPG20 interacts with the WW domains of WWP1 via its PPxY motif.   (A) Schematic representation of the Spartin/SPG20 protein showing the 
MIT domain (aa 16  –  98), PPAY sequence (aa 171  –  174), and Troyer syndrome frameshift mutant (deletion of nt 1,110 at aa 370 to truncate the 666-aa 
protein at aa 398). (B) Coprecipitation of WWP1 and SPG20. Unfused GST or GST-SPG20 was coexpressed with YFP or YFP-WWP1 in 293T cells, and 
cell lysates as well as the glutathione-bound fraction were analyzed by Western blotting with     -GST and     -GFP antibodies. (C) GST-WWP1 coprecipita-
tion experiments with YFP fused to wild-type SPG20, SPG20 lacking the PPxY domain (SPG20dPY), SPG20 lacking the MIT domain (SPG20dMIT), the 
Troyer syndrome mutant SPG20 (SPG20-1110mt), or the isolated SPG20 MIT domain (SPG20-MIT). Mwt, molecular weight; WB, Western blot. (D  –  G) 
Yeast two-hybrid analysis of interactions between SPG20 and HECT ubiquitin ligases.     -Galactosidase activity measured in yeast transformed with Gal4 
DNA-binding domain fusion proteins and VP16 activation domain fusion proteins expressed in optical density units (OD590). (D) Yeast two-hybrid analysis 
interactions between a Gal4-SPG20 and WW domains of Nedd4, Nedd4-L, Bul-1, Smurf1, and Smurf2. (E) Yeast two-hybrid analysis interactions between 
a Gal4-SPG20 and full-length WWP1, WWP2, and Itch. (F) Yeast two-hybrid analysis of Gal4-WWP1 binding to the various SPG20 mutants described 
in C. (G) Yeast two-hybrid analysis of Gal4-SPG20 binding to the various domains of WWP1: the N-terminal C2 domain, the central (PPxY binding) WW 
domains, and the C-terminal catalytic HECT domain. (H) Images of 293T cells transiently overexpressing CFP-SPG20 and either unfused YFP (top) or YFP-
WWP1 (middle and bottom). Two different optical sections from a stack of deconvolved images are shown in the middle and bottom panels. Error bars 
represent the standard deviation of the mean. Bars, 10   μ  m.     JCB • VOLUME 184 • NUMBER 6 • 2009  884
transport vesicles (mannose-6-phosphate receptor [M6PR]) as 
well as transfected markers for recycling endosomes (CFP-
Rab11) and markers of secretory granules (Che-Vamp2 and 
pCDNA-prolactin). We found no colocalization with these markers 
(  Fig. 3 A   and not depicted). However, some of the SPG20-positive 
vesicles were positive for transiently expressed Che-tagged Cav1 
( Fig.  3  B ).  Additionally, although we did not detect any YFP-
SPG20 signal in Cav3 puncta at the plasma membrane, we did 
observe substantial colocalization of YFP-SPG20 with Che-
Cav3 on spherical intracellular structures (  Fig. 3 B  ). 
  We also noticed that YFP-SPG20 colocalized perfectly 
with spheres that were easily visible using phase-contrast micros-
copy (  Fig. 3 C  ). The unique appearance of these vesicles as well 
as the colocalization with caveolins (  Martin and Parton, 2005  ) 
suggested that YFP-SPG20 – labeled spheres might represent LDs. 
Upon staining with the LD marker Oil red 0, we found that YFP-
SPG20 perfectly encircled Oil red 0  –  positive spheres (  Fig. 3 D  , 
top). Similarly, examination of a Che-SPG20  –  expressing HeLa 
cell line revealed that Che-SPG20 also localized as spheres. These 
spheres could be stained with boron-dipyrromethene (BODIPY) 
493/503, another fl  uorescent marker of LDs, with the Che-SPG20 
signal surrounding the BODIPY 493/503  –  stained LDs (  Fig. 3 D  , 
middle and bottom). 
  Next, we compared the localization of the wild-type YFP-
SPG20 protein with two YFP-SPG20 mutants. In particular, we 
used the YFP-SPG20dPY mutant that no longer binds to WWP1 
and an SPG20 mutant found in individuals with Troyer syndrome 
(YFP-SPG20-1110mt), in which a single nucleotide deletion at 
position 1,110 of the 2,001-nt SPG20 mRNA causes a frame shift 
after aa 369 and expression of a truncated 398-aa protein (wild-
type SPG20 is 666 aa). The PPxY motif, and by inference the 
ability of SPG20 to bind to WWP1, was not required for LD local-
ization (  Fig. 4 A  ). However, the Troyer syndrome SPG20 protein 
was diffusely distributed and did not localize to LDs (  Fig. 4 B  ). 
  Stable expression of YFP-SPG20 in 293T cells by trans-
duction with a retroviral vector resulted in lower levels of SPG20 
than in HeLa/YFP-SPG20 cells, as indicated by Western blotting 
(unpublished data). Under these conditions, YFP-SPG20 was 
not localized to LDs and instead was diffusely distributed in the 
cytoplasm (  Fig. 4 B  ). The addition of the fatty acid OA has been 
shown to stimulate LD formation in a variety of nonadipose cell 
types (  Xu et al., 2005  ;   Smirnova et al., 2006  ;   Bostrom et al., 
2007  ;   Fei et al., 2008  ), and, strikingly, a signifi  cant proportion of 
the diffuse YFP-SPG20 was redistributed to LDs upon addition of 
OA to the culture medium of 293T/YFP-SPG20 cells (  Fig. 4 B  ). 
However, stably expressed YFP-SPG20-1110mt did not respond 
to OA in this way, confi  rming that the recruitment of SPG20 to 
LDs was dependent on the C-terminal portion of the protein that 
is missing in Troyer syndrome (  Fig. 4 B  ). 
  To ensure that the LD localization of YFP-SPG20 and Che-
SPG20 was not an artifact of fl  uorescent protein tagging, we gen-
erated a HeLa cell line stably expressing HA-tagged SPG20 
(HA-SPG20). The levels of HA-SPG20 in this cell line were lower 
than YFP-SPG20 and Che-SPG20 stably expressed in HeLa cells 
(  Fig. S3  ). Indeed, HA-SPG20 was expressed at approximately 
equivalent levels to the endogenous HeLa cell SPG20 (Fig. S3 A). 
In these cells, a diffuse cytoplasmic staining was evident with 
protein (Che), or the HA antigen tag. In each cell line, the tagged 
SPG20 protein localized in spherical, apparently vesicular 
structures. Because SPG20 was reported to bind EPS15 and be-
cause proteins encoding MIT domains often bind to cellular 
factors involved in endosomal traffi   cking, we determined 
whether stably expressed YFP-SPG20 colocalized to endosome 
markers. These included endogenous markers for early and late 
endosomes (EEA1 and CD63) and late endosome to Golgi 
  Figure 2.       Virus particle release assays to demonstrate interactions be-
tween SPG20 and HECT ubiquitin ligases within cells.   (A) Release of virions 
from cells transfected with MLV constructs encoding either the unmodiﬁ  ed 
PPPY domain or one in which the PPPY motif was replaced with a region 
encompassing the SPG20-PPxY sequence (MLV-SPG20). Virions were 
generated in the presence or absence of the WWP1dHECT protein, and 
blots were probed with an     -MLV capsid antibody. Mwt, molecular weight. 
(B) Measurement of infectious virions generated by MLV, MLV-SPG20, or an 
MLV encoding the HIV-p6  –  derived PTAP motif (MLV-p6). Virions containing 
the pMSCV/Tat vector were generated in the presence or absence of the 
WWP1dHECT protein and were quantitated by measuring     -galactosidase 
activity after inoculation of TZM cells. RLU, relative light unit. (C) Western 
blot analysis of cell lysates and released MLV virion particles from 293T cells 
cotransfected with an unmodiﬁ  ed MLV provirus along with YFP alone or YFP 
fused to SPG20, SPG20dPY, SPG20dMIT, or SPG20dPYdMIT. Blots were 
probed with     -GFP (top) or     -MLV capsid (bottom) antibodies. (D) Infectious 
virion release from cells transfected with MLV or MLV-p6 in the presence or 
absence of SPG20. Infectious virions were measured using TZM indicator 
cells as in B and are expressed as a percentage of control uninhibited virion 
release. Error bars represent the standard deviation of the mean.     885 SPG20 AND LIPID DROPLETS   • Eastman et al. 
TIP47-GST and YFP-SPG20 (  Fig. 5 B  ) revealed that the two pro-
teins could be coprecipitated. Interestingly, the Troyer syndrome 
SPG20 variant (SPG20-1110mt) did not bind TIP47 (  Fig. 5 C  ), 
whereas SPG20 proteins lacking either the MIT domain or the 
PPxY motif bound to TIP47 as effi  ciently as intact SPG20. 
  A transiently expressed Che-tagged TIP47 (TIP47-Che) 
exhibited a mixture of diffuse and LD-localized fl  uorescence 
(confi  rmed by labeling with BODIPY 493/503;   Fig. S4   and not 
depicted). However, coexpression of TIP47-Che with YFP-SPG20 
in 293T cells resulted in substantial colocalization of the two over-
expressed proteins on LDs that coalesced together (Fig. S4). 
Moreover, endogenous TIP47 detected by immunofl  uorescent 
staining nearly perfectly colocalized with YFP-SPG20 on LDs 
in HeLa/YFP-SPG20 cells (  Fig. 5 D  ). Notably, the distribution 
of TIP47 in these cells was distinct from that in HeLa cells ex-
pressing YFP alone (  Fig. 5 D  ), as SPG20/TIP47-positive LDs 
appeared to group together. 
some degree of HA-SPG20 localization on LDs (  Fig. 4 C  , top). 
However, notably, when the HeLa/HA-SPG20 cells were cultured 
in the presence of OA, localization of HA-SPG20 to BODIPY-
positive LDs became prominent (  Fig. 4 C  , bottom) without effects 
on the HA-SPG20 expression levels (Fig. S3 B). Interestingly, OA 
reproducibly caused the appearance of low levels of higher mole  c-
ular weight forms of HA-SPG20/SPG20, perhaps suggesting 
that SPG20 ubiquitination had been induced. 
  SPG20 interacts with and colocalizes with 
the LD protein TIP47 
  Next, we used yeast two-hybrid experiments to test for inter-
actions between SPG20 and a selection of proteins known to be 
associated with LDs, including ADRP, TIP47, Rab18, Arf-1, 
Cav1, and Cav3. Notably, SPG20 bound to TIP47 but not to 
the other proteins tested (  Fig. 5 A  ). Confi  rmatory assays in 
which 293T cells were cotransfected with plasmids expressing 
  Figure 3.       SPG20 localizes to LDs.   (A) Immunoﬂ  uorescent localization of endosome markers (EEA1 and CD63; red) in a cell line (HeLa/YFP-SPG20) stably 
expressing a YFP-SPG20 fusion protein (green; images represent projections of deconvolved image stacks). (B) Localization of Che-tagged caveolin pro-
teins (Cav1-Che and Cav3-Che; red) after transient expression in HeLa/YFP-SPG20 cells. Expanded views of the boxed areas in the overlay images are 
shown to the right. (C) Phase-contrast (left) and ﬂ  uorescent (right) images of HeLa/YFP-SPG20 cells. An expanded view of the boxed area is shown below. 
(D) Staining of HeLa cells with LD markers. HeLa/YFP-SGP20 cells were stained with the LD marker Oil red O (top), whereas HeLa/Che-SPG20 cells were 
stained using the LD marker BODIPY 493/503 (middle). An expanded view of the boxed area in the BODIPY 493/503  –  stained HeLa/Che-SPG20 is 
shown in the bottom panels. Bars, 10   μ  m.     JCB • VOLUME 184 • NUMBER 6 • 2009  886
displacement of ADRP from LDs, similar to wild-type YFP-
SPG20, but the YFP-SPG20-1110mt that is defi  cient in LD local-
ization did not affect Che-ADRP localization (unpublished data). 
 Additionally,  immunofl  uorescent analysis of HeLa cells 
stably expressing Che-ADRP revealed that the LDs in the ma-
jority of Che-ADRP  –  expressing cells did not display TIP47 on 
their surfaces (  Fig. 6 C  ), which is in contrast to the untrans-
duced HeLa cells in which TIP47 was clearly present on the 
LDs in the majority of cells. Similar results have recently been 
reported by others, in which ADRP was shown to reduce the as-
sociation of several proteins with LD surfaces (  Listenberger et al., 
2007  ). In a small subset of cells expressing detectable levels of 
TIP47 on LDs, apparently reduced levels of Che-ADRP were 
present (  Fig. 6 D  ). In these cells, in which both Che-ADRP and 
TIP47 were detectable, they tended to localize to different areas 
on the surface of individual LDs (  Fig. 6 D  ). 
  SPG20 and TIP47 mark LD surfaces 
distinct from those occupied by ADRP 
  To determine whether SPG20 colocalized with another marker of 
LDs, we transduced HeLa YFP-SPG20 cells with a retroviral vec-
tor expressing Che-tagged ADRP (Che-ADRP). Notably, YFP-
SPG20 was displaced from LDs in cells expressing Che-ADRP 
(  Fig. 6 A  , top). In a reciprocal experiment, a HeLa cell line stably 
expressing Che-ADRP was transduced with a YFP-SPG20  – 
expressing retroviral vector, and a reduced Che-ADRP associa-
tion with LDs was observed in cells expressing high levels of 
YFP-SPG20 (  Fig. 6 A  , bottom). Again, the retroviral vector ex-
pressing only YFP had no effect on Che-ADRP distribution (un-
published data). In cells expressing lower levels of YFP-SPG20, 
some of the LDs were labeled with both YFP-SPG20 and Che-
ADRP (  Fig. 6 B  ). Transduction with retroviral vectors express-
ing either YFP-SPG20dPY or YFP-SPG20dMIT resulted in the 
  Figure 4.       The C-terminal region of SPG20 that is absent in the Troyer syndrome variant is required for LD targeting.   (A) HeLa cell lines stably expressing 
YFP-SPG20, YFP-SPG20dPY, or YFP-SPG20-1110mt were visualized using phase contrast (top) and ﬂ  uorescence (bottom). LDs, which are present in all 
cells, can be seen as dark spheres and are more prominent in the presence of YFP-SPG20 and YFP-SPG20dPY. (B) 293T cells stably expressing YFP-SPG20 
(left) or YFP-SGP20-1110mt (right) under normal culture conditions (top) or after incubation for 18 h with OA (bottom). Note that in 293T cells, expression 
of the YFP fusion proteins is lower than in HeLa cells, and YFP-SPG20 appears diffuse under normal culture conditions (top left). (C) Localization of HA-
tagged SPG20. HeLa cells stably expressing HA-SPG20 were cultured in the absence (top) or presence (bottom) of OA and stained with antibody to the 
HA epitope tag (red) and with BODIPY 493/53 (green). An expanded view of LDs present in the area of the images bounded by the white boxes is shown 
below each image set. Bars, 10   μ  m.     887 SPG20 AND LIPID DROPLETS   • Eastman et al. 
SPG20 protein was often reduced upon overexpression of WWP1 
as compared with a control protein (YFP) or WWP1 (C890S), 
which is presumably the result of proteosome-mediated degrada-
tion. Other LD resident proteins (expressed as GST fusion 
proteins), including TIP47, were either not ubiquitinated or 
only exhibited traces of ubiquitination upon coexpression with 
WWP1 (  Fig. 7 B  ). 
  Microscopic examination of HeLa/YFP-SPG20 cells co-
expressing Che-fused WWP1 (Che-WWP1) revealed that over-
expression of Che-WWP1 inhibited the accumulation of YFP-
SPG20 protein on LDs (or alternatively induced the removal 
of YFP-SPG20 from LDs;   Fig. 7 C  , middle), whereas unfused 
Che had no effect (  Fig. 7 C  , top). This could have been caused 
by the specifi  c removal of the LD-associated YFP-SPG20 
fraction or, alternatively, caused by the reduction in the 
overall YFP-SPG20 levels and consequent reduction in LD 
asso  ciation. Che-WWP1 lacking the catalytic HECT domain 
(Che-WWP1dHECT) did not prevent YFP-SPG20 accumula-
tion on LDs and actually appeared to enhance the YFP-SPG20 
signal on LDs, where Che-WWP1dHECT was colocalized 
(  Fig. 7 C  , bottom). 
  WWP1 can induce SPG20 ubiquitination 
and degradation and prevents SPG20 
accumulation on LDs 
  The HECT ubiquitin ligase WWP1 and SPG20 can clearly bind 
to each other and colocalize (  Figs. 1 and 2  ); therefore, we de-
termined whether there was a functional consequence of this 
interaction. To accomplish this, we coexpressed a GST-tagged 
version of SPG20 (or MLV Gag as a control) with WWP1 and 
HA-tagged ubiquitin (HA-ubiquitin). Western blot analysis of 
glutathione-agarose  –  precipitated proteins revealed that a small 
fraction of SPG20 was monoubiquitinated in the absence of 
overexpressed WWP1. Notably, SPG20 ubiquitination was 
stimulated by overexpression of WWP1 and inhibited by a cata-
lytically inactive WWP1 point mutant (C890S;   Fig. 7 A  ). The 
predominant ubiquitinated SPG20 species observed was mono-
ubiquitinated, as indicated by the     10-kD larger form of SPG20 
that was sometimes detected in whole cell lysates ( Fig. 7, A and B ) 
and the dominant anti-HA reactive species in glutathione-agarose 
precipitates. However, additional ubiquitinated species were 
detected in the glutathione-agarose – precipitated GST-SPG20 
fraction (  Fig. 7, A and B  ), and the total amount of cellular 
  Figure 5.       SPG20 interacts with TIP47.   (A) Directed yeast two-hybrid analysis of interactions between Gal4-SPG20 and candidate LD-associated proteins 
(Cav1, Cav3, ADRP, Rab18, TIP47, and Arf-1) fused to the VP16 activation domain. WWP1 is included as a positive control. (B) GST coprecipitation of YFP-
SPG20 and TIP47-GST. Unfractionated 293T cell lysates and proteins bound to glutathione-agarose were detected by Western blotting with     -GFP and     -GST 
antibodies. WB, Western blot. (C) Yeast two-hybrid analysis of interactions between SPG20 and TIP47. The DNA-binding constructs containing full-length 
SPG20, SPG20dPY, SPG20dMIT, and SPG20-1110mt were tested against the VP16 activation domain fused to WWP1 or TIP47. Gal4-Rab9 was included 
in the experiment as a control for TIP47 binding. (D) Colocalization of SPG20 and TIP47. Endogenous TIP47 is stained with an     -TIP47 monoclonal antibody 
in HeLa cells stably expressing either YFP-SPG20 (top) or unfused YFP (bottom). Error bars represent the standard deviation of the mean. Bars, 10   μ  m.     JCB • VOLUME 184 • NUMBER 6 • 2009  888
under basal conditions (unpublished data). However, when cells 
were cultured with OA for 2 d, SPG20 depletion had a marked 
effect on LD accumulation. Specifi  cally, SPG20-depleted cells 
contained a clearly increased amount of BODIPY 493/503  –
  stained LDs as compared with control vector  –  transduced cells 
(  Fig. 8 C  ). We quantitated this difference by measuring the total 
number and size of LDs in randomly selected fi  elds in the cell 
monolayer (  Fig. 8 D  ). Both parameters were increased in 
SPG20-depleted cells as compared with control vector  –  transduced 
cells, and when both LD size and numbers were accounted for 
and assuming that LDs are spherical, we estimated that SPG20-
depleted cells bore an approximately three- to fi  vefold greater 
total burden of LD volume as compared with control vector  –
 transduced cells. As a control, we transduced the SPG20-depleted 
cells with retroviral vectors expressing an shRNA-resistant 
form of either wild-type SPG20 (HA-SPG20-R) or a mutant 
form (HA-SPG20-1110mt-R) analogous to that found in Troyer 
syndrome and performed similar experiments. Expression 
of HA-SPG20-R could relieve the LD accumulation that was 
  Overexpression or underexpression of 
SPG20 induces LD accumulation 
  To determine whether SPG20 plays a role in LD formation or turn-
over, we overexpressed Che-SPG20 in 293T cells and subsequently 
incubated these cells with BODIPY 493/503 to label LDs. The 
presence of high levels of SPG20 (    10-fold higher than in the 
HeLa/YFP-SPG20 cells; unpublished data) caused the accumula-
tion and coalescence of LDs into perinuclear clusters where Che-
SPG20 was also concentrated (  Fig. 8 A  ). Overexpression of 
HA-SPG20 also induced perinuclear clusters of HA-SPG20 – coated 
LDs (  Fig. S5  ). This change was not observed upon overexpression 
of the Che-SPG20-1110mt or the unfused Che protein (  Fig. 8 A  ). 
  To determine whether endogenous SPG20 affected LD 
accumulation, we generated 293T cell populations expressing a 
short hairpin RNA (shRNA) directed against the SPG20 coding 
sequence. Western blot analysis revealed that SPG20 protein 
was effi  ciently depleted using this approach (  Fig. 8 B  ). Incuba-
tion of SPG20-depleted 293T cells with the fl  uorescent LD 
marker BODIPY 493/503 did not reveal any effect on LDs 
  Figure 6.       Reciprocal exclusion of SPG20, TIP47, and ADRP from LDs.   (A) Expression of ADRP displaces SPG20 from LDs and vice versa. HeLa/YFP-SPG20 
cells were transduced with a retroviral vector expressing Che-ADRP and visualized several days after infection. The images shown represent a projection of 
a deconvolved vertical stack of images, and a ﬁ  eld containing both Che-ADRP  –  positive and Che-ADRP  –  negative cells is shown (top). The reciprocal experi-
ment, in which a HeLa Che-ADRP cell line was transduced with a YFP-SPG20  –  expressing retroviral vector, is shown in the bottom panels. (B) Coresidence of 
Che-ADRP and YFP-SPG20 in cells expressing lower levels of YFP-SPG20. An expanded view of the boxed area is shown below. (C and D) HeLa/Che-ADRP 
cells stained with antibodies against endogenous TIP47 (green). Note that in C, TIP47 localization is only clearly visible in cells expressing no or low levels 
of Che-ADRP. In D, an expanded area of a cell (boxed area) expressing moderate levels of ADRP is shown, revealing coexistence of TIP47 and ADRP on 
individual LDs but apparently occupying distinct areas of the LD surface. Bars, 10   μ  m.     889 SPG20 AND LIPID DROPLETS   • Eastman et al. 
interaction with EPS15 (  Bakowska et al., 2005  ,   2007  ); however, 
we were not able to observe any effect on endocytic traffi  c upon 
siRNA-mediated knockdown of SPG20. Additionally, we were 
not able to detect any interaction of the SPG20-MIT domain 
with proteins that are involved in endocytic traffi  cking and are 
known to possess MIT interaction motifs (  Row et al., 2007  ; 
  Stuchell-Brereton et al., 2007  ;   Hurley and Yang, 2008  ) such as 
the charged multivesicular body proteins that were previously 
shown to bind to the MIT domains of VPS4 (  Martin-Serrano 
et al., 2003  ;   von Schwedler et al., 2003  ) and the SPG20-related 
protein SPG4 (Spastin;   Reid et al., 2005  ). 
  Instead, we uncovered an alternative function for SPG20. 
Notably, we found a striking localization of SPG20 on LDs in 
observed in the OA-fed, SPG20-depleted cells, whereas 
HA-SPG20-1110mt-R did not (  Fig. 8 E  ). Note that the HA-
SPG20-1110mt-R protein was expressed at substantially lower 
levels in transduced cells than was the HA-SPG20-R protein, as 
has been previously reported for the endogenous Troyer syn-
drome form of SPG20 (  Bakowska et al., 2008  ). 
  Discussion 
  The cellular function of SPG20 and the underlying basis for 
neurodegeneration observed in Troyer syndrome patients har-
boring a mutation in   SPG20   is unknown. Previous work has 
suggested that SPG20 is involved in endocytic traffi  cking through 
  Figure 7.       WWP1 can ubiquitinate SPG20 and prevent its 
accumulation on LDs.   (A) Ubiquitin transfer experiment performed 
in 293T cells cotransfected with GST-SPG20 or MLV Gag  –  GST 
along with HA-ubiquitin and unfused YFP, YFP-WWP1, or cata-
lytically inactive YFP-WWP1 (C890S). Glutathione-bound pro-
teins were analyzed by Western blotting with     -HA and     -GST 
antibodies. Mwt, molecular weight. WB, Western blot. (B) Simi-
lar to A except that cell lysates and glutathione-bound fractions 
were analyzed by Western blotting. 293T cells transfected with 
GST-SPG20, GST-TIP47, or GST-Rab18 along with YFP-WWP1 
or YFP-WWP1 (C890S) as well as HA-ubiquitin. GST-bound 
proteins were probed with antibodies against the HA tag (bot-
tom) to detect speciﬁ  c ubiquitin transfer. Cellular lysates were 
probed with antibodies against GST (top) and YFP (middle) 
to detect the corresponding fusion proteins. (C) Overexpres-
sion of WWP1 depletes SPG20 from LDs. HeLa YFP-SPG20 
cells were transduced with retroviruses expressing unfused Che 
(top), Che-WWP1 (middle), or Che-WWP1dHECT (bottom). 
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  Other studies have described diverse patterns of localiza-
tion for SPG20, including within mitochondria (  Lu et al., 2006  ), 
early and late endosomes (  Bakowska et al., 2007  ), the nucleus, 
and the TGN as well as synaptotagmin-positive synaptic vesi-
cles (  Robay et al., 2006  ). However, in some of these previous 
studies, the morphological pattern of SPG20 localization de-
picted is reminiscent of the LD staining described in this study. 
Indeed, other proteins that had been previously thought to re-
side in the mitochondria or endosomes have since been reclassi-
fi  ed as LD-localized proteins (  Wolins et al., 2001  ;   Puri et al., 
2008  ). Moreover, in contrast to the previous studies, we did not 
several cell lines, including HeLa, 293T, and SH-SY5Y neuro-
blastoma cells. At low expression levels, approximating those 
of the endogenous levels found in HeLa cells, SPG20 fusion 
proteins were found to be diffusely distributed in the cytoplasm 
with some degree of accumulation on LDs. However, SPG20 
localization to LDs was stimulated by OA feeding without af-
fecting SPG20 expression levels in a manner quite similar to 
that observed with PAT proteins such as TIP47 (  Wolins et al., 
2005  ;   Brasaemle, 2007  ). Overexpressed YFP, Che, or HA-
tagged SPG20 proteins clearly localized on LDs and, in fact, in-
duced clustering of LDs. 
  Figure 8.       Over- or underexpression of SPG20 perturbs LDs.   (A) 293T cells transfected with Che (top), Che-SPG20 (middle), or Che-SPG20-1110mt (bottom) 
and stained with the LD marker BODIPY 493/503. (B) SPG20-depleted cells generated by transduction of 293T cells with lentiviral vectors expressing an 
shRNA targeting SPG20 (shSPG0). Western blot analysis of cell lysates probed with an antibody against SPG20 (top) and against tubulin (bottom) as a 
loading control. Mwt, molecular weight. (C) Representative ﬁ  elds of control vector  –  containing (top) and shSPG20-containing (bottom) 293T cells cultured 
in the presence of 500   μ  M OA for 48 h and stained with BODIPY 493/503 to detect LDs (green). (D) The total number and size of LDs were quantiﬁ  ed 
in 10 randomly selected ﬁ  elds using the softWoRx software. (E and F) Similar experiments as shown in B  –  D elaborated by the inclusion of shSPG20 cells 
reconstituted with an shRNA-resistant form of wild-type HA-tagged SPG20 (SPG20-R) or the Troyer syndrome variant (SPG20-1110mt-R). (E) Western blots 
probed with antibodies to SPG20 (top), tubulin (loading control; middle), and HA-tagged proteins (bottom). (F) LD burden in SPG20-depleted/reconstituted 
cells determined as in D. Error bars represent the standard deviation of the mean. Bars, 10   μ  m.     891 SPG20 AND LIPID DROPLETS   • Eastman et al. 
protein such that hepatitis C virus core proteins were found to 
coat the LD and to exclude ADRP as well as cause LD aggrega-
tion in a rather similar manner to SPG20 (  Boulant et al., 2008  ). 
Notably, both overexpression and underexpression of SPG20 
induced the accumulation of LDs in cultured cells. The reasons 
for this are not clear, but we speculate that perhaps SPG20 
functions as part of a protein complex, whose stoichiometry 
(and function) could be disrupted by either overexpression or 
underexpression of SPG20. However, SPG20 overexpression 
appeared to induce tightly clustered LDs, whereas SPG20 de-
pletion induced LDs that appeared to be dispersed throughout 
the cell. The precise mechanisms underlying these effects re-
main to be determined. 
  Using a variety of assays, we found that SPG20 binds to 
HECT ubiquitin ligases via a PPxY domain in SPG20 and the 
WW domains in the HECT ligases. We also found that binding 
of WWP1 to SPG20 results in ubiquitin transfer to SPG20. Pre-
vious experiments have shown that SPG20 is monoubiquitinated 
(  Bakowska et al., 2007  ), and, concordantly, the major species 
that we observed resulting from WWP1 overexpression was 
monoubiquitinated SPG20. In addition, we found that WWP1 
overexpression reduced the levels of coexpressed SPG20 in 
cells. Although we have not defi  ned a direct role for WWP1 in 
LD morphogenesis, it is likely that HECT ubiquitin ligases 
control SPG20 localization and/or protein levels via ubiqui-
tination and, therefore, could infl  uence LD protein composi-
tion and turnover. 
  The symptoms of SPG20 mutation in Troyer syndrome 
include lower limb spasticity and are consistent with the de-
generation of long axons. However, no defects in general lipid 
metabolism such as obesity or fat deposition have been reported. 
This is perhaps surprising given our fi  ndings with SPG20, al-
though inspection of subcellular architecture, in particular that 
of LDs, in Troyer syndrome patients has not been undertaken as 
far as we are aware. It may be that axons may simply be more 
sensitive than other cell types to perturbations in LD turnover. 
There are interesting precedents linking genes involved in lipid 
turnover with diseases that have a similar presentation to Troyer 
syndrome. For example, a motor neuron disease can be caused 
by mutations of the gene encoding the neuropathy target ester-
ase (NTE) or inhibition of NTE by organophosphorus com-
pounds (  Rainier et al., 2008  ). NTE is partially localized to the 
cytoplasmic face of the ER and appears to be important for the 
proper balance of membrane lipids and the maintenance of axon 
integrity (  Glynn, 1999  ;   Zaccheo et al., 2004  ). NTE is a phos-
pholipase and is a member of the superfamily of patatin domain 
lipases that also includes the closely related lysophospholipase 
NTE-related esterase that is found on LDs and adipose tri-
glyceride lipase, which can regulate LD size in nonadipocyte 
cells (  Smirnova et al., 2006  ;   Kienesberger et al., 2008  ). Addi-
tionally, mutation of another human protein, Seipin (BSCL2), 
has also been shown to be associated with motor neuron dis-
orders, including wasting of distal limb muscles and lower 
limb spasticity ( Agarwal and Garg, 2004 ;  Ito and Suzuki, 2007 ). 
Interestingly, yeast lacking a functional homologue of Seipin 
(FLD1) contain increased levels of neutral lipids and possess ir-
regularly clustered/fused and enlarged LDs, a defect that can be 
detect an SPG20 colocalization with endosomal markers (EEA1 
or CD63), swollen late endosomes induced by expression 
of dominant-negative VPS4, or with mitochondria marked by 
either a resident fl  uorescent protein (DsRed-Mito) or MitoTracker 
(unpublished data). However, we did detect LDs labeled with 
YFP-SPG20 in the vicinity of both VPS4-induced endosomes 
and mitochondria. Interestingly, two studies have found that 
LDs exist in close proximity to mitochondria within adipocytes 
(  Cohen et al., 2004  ;   Brasaemle, 2007  ), and it is quite likely that 
the localization of SPG20 to mitochondria or endosomal com-
partments that has been reported was actually SPG20 on LDs. 
This may have been diffi  cult to resolve using the microscopic 
techniques used in those studies (  Lu et al., 2006  ;   Robay et al., 
2006  ;   Bakowska et al., 2007  ). Importantly, we found that the 
SPG20-1110mt protein failed to associate with LDs. The portion 
of SPG20 that is disrupted in the SPG20-1110mt protein contains 
a poorly defi   ned plant-related senescence domain (  Ciccarelli 
et al., 2003  ), and, therefore, it is plausible that the senescence 
domain is an LD-targeting domain. Indeed, targeting of SPG20 
to LDs may stabilize SPG20 levels in vivo because a recent 
study has shown that cells isolated from Troyer syndrome 
patients contain undetectable levels of SPG20-1110mt mutant 
protein (  Bakowska et al., 2008  ). 
  Although several recent studies have identifi  ed numerous 
proteins associated with LDs using either proteomic or func-
tional genomic screens (  Beller et al., 2006  ,   2008  ;   Cermelli 
et al., 2006  ;   Sato et al., 2006  ;   Bartz et al., 2007  ;   Greenberg and 
Obin, 2008  ;   Guo et al., 2008  ), SPG20 has yet to be identifi  ed as 
LD associated. This is in keeping with the diffuse pattern of lo-
calization that we found upon low levels of SPG20 expression. 
Indeed, SPG20 only became highly enriched on LDs when 
overexpressed or when cells were fed with OA. Nonetheless, 
consistent with the notion that SPG20 can genuinely localize to 
LDs, we also found that SPG20 interacted with TIP47. Impor-
tantly, this interaction required the C-terminal region of SPG20 
that is lost in the Troyer syndrome mutant protein and is also re-
quired for LD association. Moreover, we found that overexpres-
sion of a YFP-tagged version of SPG20 caused a dramatic 
accumulation of endogenous TIP47 to clustered LDs that were 
also SPG20 positive. Notably, previous work has shown that 
TIP47 and ADRP mark distinct populations of LDs that appear 
to be at different stages of maturation. Specifi  cally, shortly after 
OA treatment of adipocytes, TIP47 has been found to be associ-
ated with small lipid accumulations at the cell periphery that 
subsequently develop into mature LDs, and TIP47 is simultane-
ously replaced by ADARP (  Wolins et al., 2005  ;   Ohsaki et al., 
2006  ;   Listenberger et al., 2007  ). In addition, another protein as-
sociated with the LD, Rab18, has been shown to displace ADRP 
from LDs upon overexpression (  Ozeki et al., 2005  ). In this 
study, we found a similar relationship between SPG20 and 
ADRP, as the presence of SPG20 and ADRP on LDs appeared 
to be mutually exclusive. Cells expressing high levels of SPG20 
had quite low or undetectable levels of ADRP on LDs and vice 
versa. Thus, SPG20 behaved similarly to TIP47 and bound to 
TIP47. Therefore, TIP47/SPG20 may compete with ADRP for 
binding sites on the LD surface. Curiously, a similar phenotype 
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the pMSCV-Tat vector, infectious virions in culture supernatants were mea-
sured using TZM cells as targets (TZM cells contain an integrated HIV long 
terminal repeat driving the expression of LacZ). At 48 h after infection, cells 
were lysed, and     -galactosidase activity was measured. Infectious virions 
generated using the pMSCV-GFP vector were measured using HeLa cells as 
targets. 48 h after infection, cells were trypsinized, ﬁ  xed, and analyzed by 
FACS to enumerate infected (GFP positive) cells. 
  Yeast two-hybrid assays 
  Full-length WWP1 was cloned into the pGBKT7 Gal4 DNA-binding do-
main vector and transformed into the yeast strain Y190 to be used as bait 
against a pACT2-based human testis cDNA library (Clontech Laboratories, 
Inc.) with a complexity of     2   ×   10 
6   independent clones. The screen was 
performed as previously described (  Eastman et al., 2005  ). Directed yeast 
two-hybrid experiments were also conducted in the Y190 strain trans-
formed with the pGBKT7 DNA-binding domain and pVP16 activation do-
main vectors as previously described (  Martin-Serrano et al., 2001  ). 
  TAP 
  TAP of WWP1-associated proteins was performed using modiﬁ  cations of 
published procedures (  Rigaut et al., 1999  ;   Puig et al., 2001  ). Speciﬁ  cally, 
three conﬂ  uent 10-cm dishes of 293T cells constitutively expressing either 
TAP-YFP or TAP-YFP-WWP1 were harvested, washed three times in PBS, 
lysed in buffer (10 mM Tris, pH 8.0, 150 mM NaCl, 1% NP-40, and 10% 
glycerol) for 30 min on ice, cleared of nuclei by centrifugation at 1,000 rpm 
for 10 min, and incubated with an IgG  –  Sepharose bead slurry buffer for 
20 min under rotation at 4  °  C. The column containing the beads was then 
washed three times with buffer without glycerol and washed once with to-
bacco etch virus (TEV) buffer (10 mM Tris, pH 8.0, 150 mM NaCl, 0.1% 
NP-40, 0.5 mM EDTA, and 1 mM DTT) before incubation with 25 U TEV 
protease (Invitrogen) in TEV buffer under rotation at 4  °  C overnight. The TEV 
eluate was then combined with 3 ml of calmodulin-binding buffer (10 mM 
Tris, pH 8.0, 150 mM NaCl, 1 mM magnesium acetate, 1 mM imidazole, 
2 mM CaCl  2  , 0.1% NP-40, and 10 mM     -mercaptoethanol) along with 
3   μ  l of 1 M CaCl  2   and incubated with a calmodulin bead slurry for 1 h under 
rotation at 4  °  C. The column was then washed three times with calmodulin-
binding buffer and eluted with 10 mM Tris, pH 8.0, 150 mM NaCl, 1 mM 
magnesium acetate, 1 mM imidazole, 25 mM EGTA, 0.1% NP-40, and 10 
mM     -mercaptoethanol by rotation for 30 min at 4  °  C. The eluate was com-
bined with SDS sample buffer and run on 4  –  12% Tris-glycine SDS-PAGE 
gradient gels (Invitrogen) and stained (CodeBlue). Protein species that 
were present in the TAP-YFP-WWP1 sample but not the in the TAP-YFP sam-
ples were excised and subjected to mass spectrophotometry analysis (The 
Rockefeller University Core Facility, New York, NY). 
  GST coprecipitation and ubiquitin transfer assays 
  The procedure for the GST coprecipitation assays was essentially the same 
as for the ubiquitin transfer experiments, with the exception of the input 
DNA. Speciﬁ  cally, 293T cells within 12-well dishes were transfected with 
500 ng of a pCAGGS-based plasmid expressing a GST fusion protein 
along with 750 ng of a pCR3.1/YFP-based plasmid expressing a YFP fu-
sion protein. For ubiquitin transfer assays, 750 ng pCR3.1/YFP, pCR3.1/
YFP-WWP1, or pCR3.1/YFP-WWP1 C890S and 500 ng plasmid HA-
ubiquitin were transfected along with the plasmid expressing a GST fusion 
protein. At 45 h after transfection, cells were lysed in 1 ml of GST lysis buf-
fer (50 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 
and 5% glycerol supplemented with 5 mM   N  -ethylmaleimide to inhibit de-
ubiquitination) for 10 min followed by centrifugation at 14,000 rpm. The 
postcentrifugation supernatant was incubated with glutathione-Sepharose 
for 3 h at 4  °  C and washed three times in GST wash buffer (50 mM Tris, 
pH 7.4, 150 mM NaCl, 5 mM EDTA, and 01% Triton X-100), and proteins 
were eluted with protein sample buffer, separated on SDS-PAGE gels, and 
analyzed by Western blotting. 
  Western blotting 
  Cellular lysates and viral pellets were separated on 10 or 12% SDS-PAGE 
gels, transferred to nitrocellulose, probed with monoclonal antibodies 
raised against GFP (Roche), GST (Santa Cruz Biotechnology, Inc.), HA 
(Covance), and MLV Gag p30 (R187; Rat Hybridoma no. CRL-1912; 
American Type Culture Collection) and a polyclonal antisera recognizing 
SPG20 provided by C. Blackstone (National Institutes of Health, Bethesda, 
MD) and J. Bakowska (Loyola University, Chicago, IL) followed by peroxidase-
conjugated secondary antibodies (Millipore), and developed using chemi-
luminescence (Thermo Fisher Scientiﬁ  c). 
rescued by introduction of human or mouse Seipin (  Szymanski 
et al., 2007  ;   Fei et al., 2008  ). Thus, misregulation of lipid and/or 
LD morphogenesis/metabolism can apparently lead to axonal 
damage. Collectively, these studies and our study suggest a po-
tentially important requirement for proper LD function in the 
health of motor neurons. 
  Overall, these data identify a likely function for SPG20 
and expand the range of cellular activities that are potentially 
regulated by ubiquitination and, in particular, by the HECT 
ubiquitin ligases. Further work will be required to determine 
precisely how SPG20 mutation leads to disease, but data from 
this and other studies indicate that improper regulation of LDs 
can have profound effects on neuronal health. 
  Materials and methods 
  Cells and transfections 
  293T and HeLa cells were maintained in Dulbecco  ’  s modiﬁ  ed Eagle  ’  s me-
dium supplemented with 10% fetal calf serum and gentamycin. Derivatives 
expressing YFP, Che, HA-tagged SPG20 or ADRP proteins, or TAP-YFP/
WWP1 were generated by transduction with MLV-based LNCX2 or LPCX 
viral vectors and selected with either 1.0 mg/ml G418 or 500   μ  g/ml 
puromycin, respectively. Stable SPG20 knockdown cells were created by 
transducing 293T cells with an HIV-based retroviral vector, pLENTI-
shSPG20. This vector was derived from pLENTI-3    -U6-EC-EP7 (provided by 
D. Boden, Aaron Diamond AIDS Research Center, New York, NY) by in-
serting an oligonucleotide that generated an shRNA sequence, 5    -GTA-
ACTGCCTACAATATTAACAA-3     (nt 1,795  –  1,817), targeting a 3     region 
of the SPG20 mRNA. The HA-tagged shRNA-resistant forms of SPG20 and 
the SPG20 mutant (HA-SPG20-R and HA-SPG20-1110mt-R, respectively) 
were introduced into the SPG20 knockdown 293T cells by transduction 
with LHCX-based vectors and selected with 50   μ  g/ml hygromycin. Tran-
sient transfection experiments were performed using polyethylenimine as 
the transfection reagent, as previously described (  Neil et al., 2006  ). 
  Plasmids and mutagenesis 
  Plasmids based on pCR3.1/YFP that express WWP1, other HECT ubiquitin 
ligases, and derivatives of them have previously been described (  Martin-
Serrano et al., 2005  ). The coding sequences of SPG20, TIP47, ADRP, 
Rab11, Rab18, and Cav1 and 3 were ampliﬁ  ed by PCR from human 
placenta  –  derived cDNA and inserted into the pCR3.1/YFP/CFP/Che, 
LNCX2/YFP, or LNCX2/Che plasmids for transient or stable expression of 
ﬂ  uorescent fusion proteins. Mutant forms of YFP-SPG20 were created by 
recombinant PCR-based techniques and include YFP-SPG20dPY (PPAY to 
PAAA at aa position 170  –  174), YFP-SPG20dMIT (deletion of aa 1  –  129), 
and YFP-SPG20-1110mt (deletion of A at nt position 1,110). The shRNA-
resistant form of SPG20 contains the sequence 5    -GTcACgGCaTAtAAcAT-
cAAtAA-3     from position 1,795  –  1,817 of the cDNA sequence (silent 
mutations are in lower case). 
  Virus release assays 
  MLV particle release assays were conducted using wild-type MLV or a vari-
ant, termed MLV-p6, in which a fragment of HIV-1 was inserted in place of 
the PPPY motif (  Yuan et al., 2000  ). Additionally, an MLV construct contain-
ing a fragment of SPG20, termed MLV-SPG20, was created by inserting a 
14-aa stretch of residues centered around the SPG20 PPPY sequence (PAE-
APPAYTPQAAE) in place of the MLV PPPY motif. These mutations were in-
troduced into a full-length MLV proviral plasmid and as well as into an MLV 
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and derivates. Included in the transfection was 350 ng of a transfer vector 
that was either pMSCV-Tat or pMSCV-GFP as well as 150 ng of a plasmid 
expressing the vesicular stomatitis glycoprotein envelope protein. The me-
dium was replaced 24 h after transfection, and cells and extracellular viri-
ons were harvested at 45 h after transfection. Supernatants were ﬁ  ltered 
(0.2   μ  m), and virions were harvested by centrifugation through a 20% su-
crose cushion at 14,000 rpm in a microfuge (5417R; Eppendorf) at 4  °  C 
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  Microscopy 
  Microscopy-based experiments were performed as previously described 
(  Eastman et al., 2005  ;   Martin-Serrano et al., 2005  ). In brief, HeLa or 293T 
cells were plated on 35-mM dishes containing glass coverslips (MatTek) 
and were subsequently transfected via Lipofectamine 2000 (HeLa cells; 
Invitrogen) or polyethylenimine (293T cells). Alternatively, HeLa cells stably 
expressing ﬂ   uorescent SPG20 or ADRP proteins were used. 24 h after 
transfection, cells were ﬁ  xed with 4% paraformaldehyde for 20 min and 
rinsed with 10 mM glycine in PBS. Cells were imaged in PBS using a Delta-
Vision system (Applied Precision, LLC) that included a microscope (IX70; 
Olympus) equipped with U Apochromat/340 40  ×   NA 1.35 and U Plan-
Apochromat 100  ×   NA 1.35 objectives and a camera (CoolMax HQ; 
Photo  metrics). Image acquisition and processing by iterative deconvolution 
were performed using softWoRx software (Applied Precision, LLC). In ex-
periments that included immunoﬂ   uorescent analysis of endogenous pro-
teins or ectopically expressed tagged proteins, cells were permeabilized 
after ﬁ  xation with 1% Triton X-100 in PBS and incubated with antibodies 
against EEA1 (BD), CD63 (H5C6; Developmental Studies Hybridoma 
Bank), TIP47 (ProteinTech Group, Inc.), or the HA epitope tag (Covance). 
Secondary antibodies that were used in immunoﬂ  uorescence experiments 
were labeled with Alexa Fluor 488 or 594. 
  LD visualization, induction, and quantitation assays 
  To visualize LDs, cell monolayers in MatTek dishes were rinsed with PBS 
and incubated with BODIPY 493/503 (Invitrogen) to label LDs (  Smirnova 
et al., 2006  ;   Turr  ó   et al., 2006  ). Alternatively, in some experiments, LDs 
were visualized by staining ﬁ  xed cells with Oil red O (0.6% in 60% isopro-
panol). To induce LD formation, HeLa or 293T cells were cultured with 
300  –  500   μ  M OA (Sigma-Aldrich) in 0.3% BSA (OA/BSA) for 12  –  48 h. 
For quantitation of LD burden in cells, we used BODIPY 493/503  –  stained 
cells and the softWoRx program to count the total number of LDs present in 
a projected image (a composite stack of 50 deconvolved optical sections 
acquired at 40  ×   magniﬁ  cation) and to measure the diameter of LDs present 
in all optical sections of the same deconvolved image. Thereafter, we cal-
culated the mean number and diameter of LDs present in images acquired 
from 10 randomly chosen ﬁ  elds of cells. Typically, each ﬁ  eld contained 
    50  –  70 cells. 
  Online supplemental material 
  Fig. S1 shows localization of CFP-SPG20 in 293T cells coexpressing 
YFP fusion proteins containing the various domains of WWP1. Fig. S2 
shows disruption of WWP1 to sites of MLV viral-budding Gag by SPG20 
overexpression. Fig. S3 shows YFP-SPG20, Che-SPG20, HA-SPG20, and 
endogenous SPG20 expression levels in transduced HeLa cells. Fig. S4 
shows colocalization of transiently coexpressed TIP47-Che and YFP-
SPG20. Fig. S5 shows clustered LDs induced by overexpression of HA-
SPG20. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200808041/DC1. 
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